| The Vanguard Group - 23-1945930 |
Pennsylvania |
0 |
129106 |
4731949 |
164564 |
4896513 |
5.19 % |
13/02/2024 |
| The Vanguard Group - 23-1945930 |
Pennsylvania |
0 |
129106 |
4731949 |
164564 |
4896513 |
5.19 % |
13/02/2024 |
| Morgan Stanley |
|
13 |
5362263 |
0 |
13 |
6093497 |
6.5 % |
12/02/2024 |
| Rubric Capital Management LP |
State of Delaware |
0 |
6644530 |
0 |
0 |
6644530 |
7.04 % |
12/02/2024 |
| David Rosen |
United States of America |
0 |
6644530 |
0 |
0 |
6644530 |
7.04 % |
12/02/2024 |
| David Rosen |
|
0 |
6644530 |
0 |
0 |
6644530 |
7.04 % |
12/02/2024 |
| Rubric Capital Management LP |
|
0 |
6644530 |
0 |
0 |
6644530 |
7.04 % |
12/02/2024 |
| 2 |
Delaware |
0 |
4836116 |
0 |
0 |
4836116 |
5.1 % |
31/01/2024 |
| 2 |
Delaware |
0 |
4836116 |
0 |
0 |
4836116 |
5.1 % |
31/01/2024 |
| 2 |
Delaware |
0 |
4867706 |
0 |
0 |
4867706 |
5.2 % |
31/01/2024 |
| 2 |
Delaware |
0 |
31590 |
0 |
0 |
31590 |
12 % |
31/01/2024 |
| 2 |
Delaware |
0 |
4836116 |
0 |
0 |
4836116 |
5.1 % |
31/01/2024 |
| 2 |
Delaware |
0 |
4836116 |
0 |
0 |
4836116 |
5.1 % |
31/01/2024 |
| 2 |
Delaware |
0 |
4867706 |
0 |
0 |
4867706 |
5.2 % |
31/01/2024 |
| 2 |
Delaware |
0 |
31590 |
0 |
0 |
31590 |
12 % |
31/01/2024 |
| (1) BlackRock, Inc. |
Delaware |
5883848 |
0 |
5916546 |
0 |
5916546 |
6.3 % |
29/01/2024 |
| Polar Capital Funds PLC - Biotechnology Fund |
United Kingdom |
6277966 |
0 |
6277966 |
0 |
6277966 |
6.67 % |
16/11/2023 |
| Polar Capital LLP |
United Kingdom |
7117944 |
0 |
7117944 |
0 |
7117944 |
7.56 % |
16/11/2023 |
| Polar Capital Holdings Plc |
United Kingdom |
7117944 |
0 |
7117944 |
0 |
7117944 |
7.56 % |
16/11/2023 |
| Polar Capital Holdings Plc |
United Kingdom |
7117944 |
0 |
7117944 |
0 |
7117944 |
7.56 % |
16/11/2023 |
| Polar Capital LLP |
United Kingdom |
7117944 |
0 |
7117944 |
0 |
7117944 |
7.56 % |
16/11/2023 |
| Polar Capital Funds PLC - Biotechnology Fund |
United Kingdom |
6277966 |
0 |
6277966 |
0 |
6277966 |
6.67 % |
16/11/2023 |
| Aaron Cowen |
Delaware |
0 |
9592212 |
0 |
9592212 |
9592212 |
9.99 % |
30/10/2023 |
| Suvretta Capital Management, LLC |
Delaware |
0 |
9592212 |
0 |
9592212 |
9592212 |
9.99 % |
30/10/2023 |
| Suvretta Capital Management, LLC |
Delaware |
0 |
9592212 |
0 |
9592212 |
9592212 |
9.99 % |
30/10/2023 |
| Averill Master Fund, Ltd. |
Delaware |
0 |
8716322 |
0 |
8716322 |
8716322 |
9.1 % |
30/10/2023 |
| Averill Master Fund, Ltd. |
Delaware |
0 |
8716322 |
0 |
8716322 |
8716322 |
9.1 % |
30/10/2023 |
| Aaron Cowen |
Delaware |
0 |
9592212 |
0 |
9592212 |
9592212 |
9.99 % |
30/10/2023 |
| STATE STREET CORPORATION |
|
0 |
3606359 |
0 |
3679385 |
3679385 |
6.04 % |
08/02/2023 |
| OrbiMed Advisors LLC |
|
0 |
2828356 |
0 |
10 |
2828356 |
4.7 % |
26/08/2022 |
| OrbiMed Capital LLC |
|
48144 |
0 |
48144 |
10 |
48144 |
0.1 % |
26/08/2022 |
| OrbiMed Capital GP VII LLC |
|
0 |
2828356 |
0 |
10 |
2828356 |
4.7 % |
26/08/2022 |
| Patrick J. Heron |
|
61079 |
8684239 |
61079 |
8684239 |
8745318 |
14.6 % |
09/08/2022 |
| FHM Life Sciences VIII, L.P. |
|
0 |
8684232 |
0 |
8684232 |
8684232 |
14.5 % |
09/08/2022 |
| James N. Topper |
|
30647 |
8684239 |
30647 |
8684239 |
8714886 |
14.5 % |
09/08/2022 |
| Frazier Life Sciences VIII, L.P. |
|
0 |
8684232 |
0 |
8684232 |
8684232 |
14.5 % |
09/08/2022 |
| FHM Life Sciences VIII, L.L.C. |
|
0 |
8684239 |
0 |
8684239 |
8684239 |
14.5 % |
09/08/2022 |
| OrbiMed Advisors LLC |
|
0 |
3146724 |
0 |
10 |
3146724 |
5.4 % |
08/08/2022 |
| OrbiMed Capital LLC |
|
588674 |
0 |
588674 |
10 |
588674 |
1 % |
08/08/2022 |
| OrbiMed Capital GP VII LLC |
|
0 |
3146724 |
0 |
10 |
3146724 |
5.4 % |
08/08/2022 |
| OrbiMed Advisors LLC |
Delaware |
0 |
3534537 |
0 |
10 |
3534537 |
6.9 % |
28/06/2022 |
| OrbiMed Capital LLC |
Cayman Islands |
1247109 |
0 |
1247109 |
10 |
1247109 |
2.4 % |
28/06/2022 |
| OrbiMed Capital GP VII LLC |
Delaware |
0 |
3534537 |
0 |
10 |
3534537 |
6.9 % |
28/06/2022 |
| Bain Capital Life Sciences Fund, L.P. |
|
0 |
2721436 |
0 |
2721436 |
2721436 |
5.3 % |
27/05/2022 |
| BCIP Life Sciences Associates, LP |
|
0 |
278564 |
0 |
278564 |
278564 |
0.5 % |
27/05/2022 |
| OrbiMed Capital LLC |
|
1355086 |
0 |
1355086 |
10 |
1355086 |
2.7 % |
08/04/2022 |
| OrbiMed Advisors LLC |
|
0 |
3840564 |
0 |
10 |
3840564 |
7.6 % |
08/04/2022 |
| OrbiMed Capital GP VII LLC |
|
0 |
3840564 |
0 |
10 |
3840564 |
7.6 % |
08/04/2022 |
| Point72 Capital Advisors, Inc. |
|
0 |
2644177 |
0 |
2644177 |
2644177 |
4 % |
14/02/2022 |
| Point72 Asset Management, L.P. |
|
0 |
2644177 |
0 |
2644177 |
2644177 |
4 % |
14/02/2022 |
| Steven A. Cohen |
Citizenship or place of organization United States |
0 |
2657962 |
0 |
2657962 |
2657962 |
4 % |
14/02/2022 |
| Point72 Hong Kong Limited |
Citizenship or place of organization Hong Kong |
0 |
0 |
0 |
0 |
0 |
4 % |
14/02/2022 |
| Cubist Systematic Strategies, LLC |
Citizenship or place of organization Delaware |
0 |
13785 |
0 |
13785 |
13785 |
4 % |
14/02/2022 |
| Point72 Capital Advisors, Inc. |
Citizenship or place of organization Delaware |
0 |
2644177 |
0 |
2644177 |
2644177 |
4 % |
14/02/2022 |
| Point72 Hong Kong Limited |
|
0 |
0 |
0 |
0 |
0 |
4 % |
14/02/2022 |
| Steven A. Cohen |
|
0 |
2657962 |
0 |
2657962 |
2657962 |
4 % |
14/02/2022 |
| Point72 Asset Management, L.P. |
Citizenship or place of organization Delaware |
0 |
2644177 |
0 |
2644177 |
2644177 |
4 % |
14/02/2022 |
| Cubist Systematic Strategies, LLC |
|
0 |
13785 |
0 |
13785 |
13785 |
4 % |
14/02/2022 |
| (1) BlackRock, Inc. |
Delaware |
4235652 |
0 |
4313864 |
0 |
4313864 |
8.6 % |
03/02/2022 |
| Point72 Hong Kong Limited |
Delaware |
0 |
927 |
0 |
927 |
927 |
4 % |
15/12/2021 |
| Point72 Capital Advisors, Inc. |
Delaware |
0 |
2534286 |
0 |
2534286 |
2534286 |
4 % |
15/12/2021 |
| Cubist Systematic Strategies, LLC |
Delaware |
0 |
15523 |
0 |
15523 |
15523 |
4 % |
15/12/2021 |
| Point72 Asset Management, L.P. |
Delaware |
0 |
2534286 |
0 |
2534286 |
2534286 |
4 % |
15/12/2021 |
| Point72 Asset Management, L.P. |
Delaware |
0 |
2534286 |
0 |
2534286 |
2534286 |
4 % |
15/12/2021 |
| Point72 Hong Kong Limited |
Delaware |
0 |
927 |
0 |
927 |
927 |
4 % |
15/12/2021 |
| Cubist Systematic Strategies, LLC |
Delaware |
0 |
15523 |
0 |
15523 |
15523 |
4 % |
15/12/2021 |
| Point72 Capital Advisors, Inc. |
Delaware |
0 |
2534286 |
0 |
2534286 |
2534286 |
4 % |
15/12/2021 |
| Steven A. Cohen |
Delaware |
0 |
2550736 |
0 |
2550736 |
2550736 |
4 % |
15/12/2021 |
| Steven A. Cohen |
Delaware |
0 |
2550736 |
0 |
2550736 |
2550736 |
4 % |
15/12/2021 |
| James N. Topper |
|
30647 |
8434239 |
30647 |
8434239 |
8464886 |
16.9 % |
12/05/2021 |
| Patrick J. Heron |
|
47668 |
8434239 |
47668 |
8434239 |
8481907 |
16.9 % |
12/05/2021 |
| Frazier Life Sciences VIII, L.P. |
|
0 |
8434232 |
0 |
8434232 |
8434232 |
16.8 % |
12/05/2021 |
| FHM Life Sciences VIII, L.P. |
|
0 |
8434232 |
0 |
8434232 |
8434232 |
16.8 % |
12/05/2021 |
| FHM Life Sciences VIII, L.L.C. |
|
0 |
8434239 |
0 |
8434239 |
8434239 |
16.8 % |
12/05/2021 |
| James N. Topper |
|
0 |
10542790 |
0 |
10542790 |
10542790 |
21.7 % |
09/02/2021 |
| Patrick J. Heron |
|
24000 |
10542790 |
24000 |
10542790 |
10566790 |
21.7 % |
09/02/2021 |
| Frazier Life Sciences VIII, L.P. |
|
0 |
10542790 |
0 |
10542790 |
10542790 |
21.7 % |
09/02/2021 |
| FHM Life Sciences VIII, L.P. |
|
0 |
10542790 |
0 |
10542790 |
10542790 |
21.7 % |
09/02/2021 |
| FHM Life Sciences VIII, L.L.C. |
|
0 |
10542790 |
0 |
10542790 |
10542790 |
21.7 % |
09/02/2021 |
| (1) BlackRock, Inc. |
Delaware |
2856358 |
0 |
2895054 |
0 |
2895054 |
6.6 % |
02/02/2021 |
| OrbiMed Capital LLC |
Cayman Islands |
1806286 |
0 |
1806286 |
10 |
1806286 |
4.2 % |
07/10/2020 |
| OrbiMed Capital GP VII LLC |
Delaware |
0 |
4267564 |
0 |
10 |
4267564 |
9.9 % |
07/10/2020 |
| OrbiMed Advisors LLC |
Delaware |
0 |
4267564 |
0 |
10 |
4267564 |
9.9 % |
07/10/2020 |
| FHM Life Sciences VIII, L.L.C. |
|
0 |
10542790 |
0 |
10542790 |
10542790 |
24.1 % |
06/10/2020 |
| FHM Life Sciences VIII, L.P. |
|
0 |
10542790 |
0 |
10542790 |
10542790 |
24.1 % |
06/10/2020 |
| Frazier Life Sciences VIII, L.P. |
|
0 |
10542790 |
0 |
10542790 |
10542790 |
24.1 % |
06/10/2020 |
| Patrick J. Heron |
|
0 |
10542790 |
0 |
10542790 |
10542790 |
24.1 % |
06/10/2020 |
| James N. Topper |
|
0 |
10542790 |
0 |
10542790 |
10542790 |
24.1 % |
06/10/2020 |
| OrbiMed Capital LLC |
Cayman Islands |
606286 |
0 |
606286 |
10 |
606286 |
1.6 % |
10/02/2020 |
| OrbiMed Capital LLC |
|
606286 |
0 |
606286 |
11 |
606286 |
1.6 % |
10/02/2020 |
| OrbiMed Capital GP VII LLC |
Delaware |
0 |
4067564 |
0 |
10 |
4067564 |
10.7 % |
10/02/2020 |
| OrbiMed Advisors LLC |
Delaware |
0 |
4067564 |
0 |
10 |
4067564 |
10.7 % |
10/02/2020 |
| OrbiMed Capital GP VII LLC |
|
0 |
4067564 |
0 |
11 |
4067564 |
10.7 % |
10/02/2020 |
| OrbiMed Advisors LLC |
|
0 |
4067564 |
0 |
11 |
4067564 |
10.7 % |
10/02/2020 |
| BCIP Life Sciences Associates, LP |
|
0 |
369496 |
0 |
11 |
369496 |
1 % |
07/02/2020 |
| BCIP Life Sciences Associates, LP |
|
0 |
369496 |
0 |
11 |
369496 |
1 % |
07/02/2020 |
| Bain Capital Life Sciences Fund, L.P. |
|
0 |
3609796 |
0 |
11 |
3609796 |
9.5 % |
07/02/2020 |
| Bain Capital Life Sciences Fund, L.P. |
|
0 |
3609796 |
0 |
11 |
3609796 |
9.5 % |
07/02/2020 |
| Frazier Life Sciences VIII, L.P. |
|
0 |
10542790 |
0 |
11 |
10542790 |
27.7 % |
07/02/2020 |
| FHM Life Sciences VIII, L.L.C. |
|
0 |
10542790 |
0 |
11 |
10542790 |
27.7 % |
07/02/2020 |
| James N. Topper |
|
0 |
10542790 |
0 |
11 |
10542790 |
27.7 % |
07/02/2020 |
| Patrick J. Heron |
|
0 |
10542790 |
0 |
11 |
10542790 |
27.7 % |
07/02/2020 |
| James N. Topper |
|
0 |
10542790 |
0 |
11 |
10542790 |
27.7 % |
07/02/2020 |
| FHM Life Sciences VIII, L.P. |
|
0 |
10542790 |
0 |
11 |
10542790 |
27.7 % |
07/02/2020 |
| FHM Life Sciences VIII, L.L.C. |
|
0 |
10542790 |
0 |
11 |
10542790 |
27.7 % |
07/02/2020 |
| Frazier Life Sciences VIII, L.P. |
|
0 |
10542790 |
0 |
11 |
10542790 |
27.7 % |
07/02/2020 |
| Patrick J. Heron |
|
0 |
10542790 |
0 |
11 |
10542790 |
27.7 % |
07/02/2020 |
| FHM Life Sciences VIII, L.P. |
|
0 |
10542790 |
0 |
11 |
10542790 |
27.7 % |
07/02/2020 |